Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline costa rica s.a - vitamina a - vitamina a....4000 iu / vitamina d3....0.008400g / vitamina b1....0.003192g / vitamina b2....0.003250g / niacinamida....0.015750g / vitamina b6....0.011183g / vitamina b12....0.003125g / vitamina e....0.172500g / vitamina k1....0.000750g / biotina....0.005175g / Ácido fÓlico....0.000540g / Ácido pantotÉnico....0.012499g / beta-caroteno 20%....0.011228g / vitamina c....0.097423g / calcio....0.525790g / potasio....0.152555g / hierro....0.012778g / magnesio....0.082891g / manganeso....0.016159g / zinc....0.009335g / cromo....0.000564g / cobre....0.002638g / molibdato....0.000125g / selenio....0.000145g / betacaroteno....0.011228g / luteina (flor marigold, tagetes erecta)....0.013000g / licopeno....0.008100g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline costa rica s.a - terbinafina clorhidrato - terbinafina clorhidrato....1.00 g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline costa rica s.a. - carbonato de calcio - carbonato de calcio....1666.67 mg / colecalciferol....6.20 mg

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline costa rica s.a - manganeso - manganeso....0.016159g / cromo....0.000197g / cobre....0.002638g / selenio....0.000145g / vitamina a....0.003000g / vitamina d3....0.008400g / vitamina b1....0.003192g / vitamina b2....0.003520g / vitamina e....0.115000g / vitamina k1....0.000750g / biotina....0.005175g / Ácido fÓlico....0.000540g / Ácido pantotÉnico....0.012499g / betacaroteno....0.011228g / vitamina c....0.097423g / luteina (flor marigold, tagetes erecta)....0.01300g / licopeno....0.008100g / calcio....0.525790g / potasio....0.152555g / hierro....0.031944g / magnesio....0.082891g / zinc....0.009335g / molibdeno....0.000125g / niacinamida....0.015750g / vitamina b6....0.006989g / yoduro....0.000236g / vitamina b12....0.002500g

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

glaxosmithkline costa rica s.a - vitamina a - vitamina a....0.003000g / vitamina d3....0.008400g / vitamina b1....0.003192g / vitamina b2....0.003520g / niacinamida....0.015750g / vitamina b6....0.011183g / vitamina b12....0.003125g / vitamina e....0.172500g / vitamina k1....0.000750g / biotina....0.005175g / Ácido fÓlico....0.000540g / Ácido pantotÉnico....0.012499g / vitamina c....0.097423g / calcio....0.525790g / potasio....0.152555g / hierro....0.012778g / manganeso....0.016159g / zinc....0.009335g / cromo....0.000564g / cobre....0.002638g / selenio....0.000145g / betacaroteno....0.011228g / licopeno....0.008100g / magnesio.... 0.082891g / molibdeno....0.000125g / luteÍna....0.013000g / yodo....0.000236g

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - live attenuated measles virus (schwarz strain); live attenuated mumps virus (rit4385 strain); live attenuated rubella virus (wistar ra 27/3 strain); live attenuated varicella virus (oka strain) - injection, powder, lyophilized, for solution - ≥ 10 3.0 ccid50 /dose - live attenuated measles virus (schwarz strain) ≥ 10³ ccid50/dose; live attenuated mumps virus (rit4385 strain) ≥ 10⁴·⁴ ccid50/dose; live attenuated rubella virus (wistar ra 27/3 strain) ≥ 10³ ccid50/dose; live attenuated varicella virus (oka strain) ≥ 10³·³ pfu/dose

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - diphtheria toxoid; filamentous haemagglutinin; hepatitis b surface antigen (purified); hib purified capsular polysaccharide bound to tetanus toxoid; pertactin (69 kda omp); pertussis toxoid; poliovirus type 1 (inactivated); poliovirus type 2 (inactivated); poliovirus type 3 (inactivated) - injection - min 30 iu/0.5 ml - diphtheria toxoid min 30 iu/0.5 ml; filamentous haemagglutinin 25 mcg/0.5 ml; hepatitis b surface antigen (purified) 10 mcg/0.5 ml; hib purified capsular polysaccharide bound to tetanus toxoid 10 mcg/0.5 ml; pertactin (69 kda omp) 8 mcg/0.5 ml; pertussis toxoid 25 mcg/0.5 ml; poliovirus type 1 (inactivated) 40 du/0.5 ml; poliovirus type 2 (inactivated) 8 du/0.5 ml; poliovirus type 3 (inactivated) 32 du/0.5 ml

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis b surface antigen, recombinant 20 µg/ml; hepatitis b surface antigen, recombinant 20 µg/ml - suspension for injection - 10 mcg/0.5ml - active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenoxyethanol sodium chloride thiomersal water for injection active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - engerix-b is indicated for active immunization against hepatitis b virus infection.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hepatitis b surface antigen, recombinant 20 µg/ml; hepatitis b surface antigen, recombinant 20 µg/ml - suspension for injection - 20 mcg/ml - active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate phenoxyethanol sodium chloride thiomersal water for injection active: hepatitis b surface antigen, recombinant 20 µg/ml excipient: aluminium hydroxide dibasic sodium phosphate dihydrate monobasic sodium phosphate dihydrate sodium chloride water for injection - engerix-b is indicated for active immunization against hepatitis b virus infection.

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - influenza virus a/california/7/2009 (h1n1) - like strain 30 µg/ml (a/christchurch/16/2010 (nib-74xp) (15 µg ha)); influenza virus a/hong kong/4801/2014 (h3n2) - like strain 30 µg/ml (a/hong kong/4801/2014, nymc x-263b (15 µg ha)); influenza virus b/brisbane/60/2008 - like strain 30 µg/ml (b/brisbane/60/2008 (15 µg ha)) - suspension for injection - active: influenza virus a/california/7/2009 (h1n1) - like strain 30 µg/ml (a/christchurch/16/2010 (nib-74xp) (15 µg ha)) influenza virus a/hong kong/4801/2014 (h3n2) - like strain 30 µg/ml (a/hong kong/4801/2014, nymc x-263b (15 µg ha)) influenza virus b/brisbane/60/2008 - like strain 30 µg/ml (b/brisbane/60/2008 (15 µg ha)) excipient: commercial light duty detergent d-alpha-tocopheryl acid succinate dibasic sodium phosphate dodecahydrate formaldehyde gentamicin sulfate magnesium chloride hexahydrate monobasic potassium phosphate potassium chloride sodium chloride sodium deoxycholate sucrose water for injection - fluarix is indicated for prophylaxis against influenza in adults and children older than six months of age.